Annual Retained Earnings
-$25.42 M
-$2.22 M-9.54%
September 1, 2024
Summary
- As of February 7, 2025, DRUG annual retained earnings is -$25.42 million, with the most recent change of -$2.22 million (-9.54%) on September 1, 2024.
- During the last 3 years, DRUG annual retained earnings has fallen by -$18.20 million (-252.11%).
- DRUG annual retained earnings is now -5986.52% below its all-time high of -$417.70 thousand, reached on September 30, 2020.
Performance
DRUG Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$25.42 M
-$910.30 K-3.71%
September 1, 2024
Summary
- As of February 7, 2025, DRUG quarterly retained earnings is -$25.42 million, with the most recent change of -$910.30 thousand (-3.71%) on September 1, 2024.
- Over the past year, DRUG quarterly retained earnings has dropped by -$373.40 thousand (-1.49%).
- DRUG quarterly retained earnings is now -5986.52% below its all-time high of -$417.70 thousand, reached on September 1, 2020.
Performance
DRUG Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
DRUG Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.5% | -1.5% |
| 3 y3 years | -252.1% | -1.5% |
| 5 y5 years | -5986.5% | -1.5% |
DRUG Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -252.1% | at low | -130.4% | at low |
| 5 y | 5-year | -5986.5% | at low | -5986.5% | at low |
| alltime | all time | -5986.5% | at low | -5986.5% | at low |
Bright Minds Biosciences Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | -$25.42 M(+9.5%) | -$25.42 M(+3.7%) |
| Jun 2024 | - | -$24.51 M(-2.0%) |
| Mar 2024 | - | -$25.02 M(-0.1%) |
| Dec 2023 | - | -$25.05 M(+7.9%) |
| Sep 2023 | -$23.21 M(+31.3%) | -$23.21 M(+2.5%) |
| Jun 2023 | - | -$22.65 M(+7.3%) |
| Mar 2023 | - | -$21.12 M(+8.1%) |
| Dec 2022 | - | -$19.53 M(+10.5%) |
| Sep 2022 | -$17.68 M | -$17.68 M(+7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -$16.46 M(+10.8%) |
| Mar 2022 | - | -$14.86 M(+34.7%) |
| Dec 2021 | - | -$11.03 M(+52.8%) |
| Sep 2021 | -$7.22 M(+1628.6%) | - |
| Sep 2021 | - | -$7.22 M(+41.1%) |
| Jun 2021 | - | -$5.12 M(+129.8%) |
| Mar 2021 | - | -$2.23 M(+116.2%) |
| Dec 2020 | - | -$1.03 M(+146.4%) |
| Sep 2020 | -$417.70 K | - |
| Sep 2020 | - | -$417.70 K |
FAQ
- What is Bright Minds Biosciences annual retained earnings?
- What is the all time high annual retained earnings for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual retained earnings year-on-year change?
- What is Bright Minds Biosciences quarterly retained earnings?
- What is the all time high quarterly retained earnings for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly retained earnings year-on-year change?
What is Bright Minds Biosciences annual retained earnings?
The current annual retained earnings of DRUG is -$25.42 M
What is the all time high annual retained earnings for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual retained earnings is -$417.70 K
What is Bright Minds Biosciences annual retained earnings year-on-year change?
Over the past year, DRUG annual retained earnings has changed by -$2.22 M (-9.54%)
What is Bright Minds Biosciences quarterly retained earnings?
The current quarterly retained earnings of DRUG is -$25.42 M
What is the all time high quarterly retained earnings for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly retained earnings is -$417.70 K
What is Bright Minds Biosciences quarterly retained earnings year-on-year change?
Over the past year, DRUG quarterly retained earnings has changed by -$373.40 K (-1.49%)